In 3 patients, the baseline IL-6 level was <500 ng/L, and the indications for CytoSorb use were hyperbilirubinemia, rhabdomyolysis, and leukemia with capillary leak syndrome. This evidence concerns the gene IL6 and capillary leak syndrome.